This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM et al. Targeted disruption of SHIP leads to hemopoietic perturbations lung pathology, and a shortened life span. Genes Dev 1998; 12: 1610–1620.
Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189–218.
Evans CA, Tonge R, Blinco D, Pierce A, Shaw J, Lu Y et al. Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 2004; 103: 3751–3759.
Gray A, van der Kaay J, Downes CP . The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem J 1999; 344: 929–936.
Holyoake TL, Jiang X, Jorgensen HG, Graham S, Alcorn MJ, Laird C et al. Primitive quiescent leukaemic cells from patients with chronic myeloid leukaemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. Blood 2001; 97: 720–728.
Whetton AD, Lu Y, Pierce A, Carney L, Spooncer E . Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1. Blood 2003; 102: 2798–2802.
Acknowledgements
This work was supported by the UK and NI Leukaemia Research Funds and the MRC. HG Hamzah is the recipient of a Borno State Scholarship, Federal Republic of Nigeria.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamzah, H., Pierce, A., Stewart, W. et al. Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib. Leukemia 19, 1851–1853 (2005). https://doi.org/10.1038/sj.leu.2403919
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403919